BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24846694)

  • 1. Proteomics of Fuchs' endothelial corneal dystrophy support that the extracellular matrix of Descemet's membrane is disordered.
    Poulsen ET; Dyrlund TF; Runager K; Scavenius C; Krogager TP; Højrup P; Thøgersen IB; Sanggaard KW; Vorum H; Hjortdal J; Enghild JJ
    J Proteome Res; 2014 Nov; 13(11):4659-67. PubMed ID: 24846694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of apolipoprotein E and immunoglobulin heavy constant gamma 1 proteins in Fuchs endothelial corneal dystrophy.
    Kuot A; Ronci M; Mills R; Klebe S; Snibson G; Wiffen S; Loh R; Corbett M; Zhou T; Chataway T; Burdon KP; Craig JE; Urbani A; Sharma S
    Clin Exp Ophthalmol; 2019 Nov; 47(8):1028-1042. PubMed ID: 31206232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The composition of wide-spaced collagen in normal and diseased Descemet's membrane.
    Levy SG; Moss J; Sawada H; Dopping-Hepenstal PJ; McCartney AC
    Curr Eye Res; 1996 Jan; 15(1):45-52. PubMed ID: 8631203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Descemet's membrane/posterior collagenous layer isolated from Fuchs' endothelial dystrophy corneas.
    Kenney MC; Labermeier U; Hinds D; Waring GO
    Exp Eye Res; 1984 Sep; 39(3):267-77. PubMed ID: 6389163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Matrix and Integrin Expression Profiles in Fuchs Endothelial Corneal Dystrophy Cells and Tissue Model.
    Goyer B; Thériault M; Gendron SP; Brunette I; Rochette PJ; Proulx S
    Tissue Eng Part A; 2018 Apr; 24(7-8):607-615. PubMed ID: 28726551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-dimensional gel electrophoretic comparison of endothelial cell-Descemet's membrane proteins in Fuchs' dystrophy and normal corneas.
    Wilson SE; Lloyd SA; Lloyd WC
    Cornea; 1992 Jul; 11(4):315-8. PubMed ID: 1424651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix alterations in late-onset Fuchs' corneal dystrophy.
    Weller JM; Zenkel M; Schlötzer-Schrehardt U; Bachmann BO; Tourtas T; Kruse FE
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3700-8. PubMed ID: 24833739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products and receptors in Fuchs' dystrophy corneas undergoing Descemet's stripping with endothelial keratoplasty.
    Wang Z; Handa JT; Green WR; Stark WJ; Weinberg RS; Jun AS
    Ophthalmology; 2007 Aug; 114(8):1453-60. PubMed ID: 17320180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fuchs corneal dystrophy: aberrant collagen distribution in an L450W mutant of the COL8A2 gene.
    Gottsch JD; Zhang C; Sundin OH; Bell WR; Stark WJ; Green WR
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4504-11. PubMed ID: 16303941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colocalization of increased transforming growth factor-beta-induced protein (TGFBIp) and Clusterin in Fuchs endothelial corneal dystrophy.
    Jurkunas UV; Bitar M; Rawe I
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1129-36. PubMed ID: 19011008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomechanical changes to Descemet's membrane precede endothelial cell loss in an early-onset murine model of Fuchs endothelial corneal dystrophy.
    Leonard BC; Jalilian I; Raghunathan VK; Wang W; Jun AS; Murphy CJ; Thomasy SM
    Exp Eye Res; 2019 Mar; 180():18-22. PubMed ID: 30471280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases and their inhibitors in Fuchs endothelial corneal dystrophy.
    Xu I; Thériault M; Brunette I; Rochette PJ; Proulx S
    Exp Eye Res; 2021 Apr; 205():108500. PubMed ID: 33617849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained Activation of the Unfolded Protein Response Induces Cell Death in Fuchs' Endothelial Corneal Dystrophy.
    Okumura N; Kitahara M; Okuda H; Hashimoto K; Ueda E; Nakahara M; Kinoshita S; Young RD; Quantock AJ; Tourtas T; Schlötzer-Schrehardt U; Kruse F; Koizumi N
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3697-3707. PubMed ID: 28727885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shotgun proteomics identification of proteins expressed in the Descemet's membrane of patients with Fuchs endothelial corneal dystrophy.
    Nakagawa T; Okumura N; Ikegawa M; Toyama Y; Nirasawa T; Mascarelli F; Vaitinadapoule H; Aouimeur I; He Z; Gain P; Thuret G; Koizumi N
    Sci Rep; 2023 Jun; 13(1):10401. PubMed ID: 37369713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential gene expression analysis of corneal endothelium indicates involvement of phagocytic activity in Fuchs' endothelial corneal dystrophy.
    Kuot A; Corbett MA; Mills RA; Snibson G; Wiffen S; Loh R; Burdon KP; Craig JE; Sharma S
    Exp Eye Res; 2021 Sep; 210():108692. PubMed ID: 34228965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomechanical relationships between the corneal endothelium and Descemet's membrane.
    Ali M; Raghunathan V; Li JY; Murphy CJ; Thomasy SM
    Exp Eye Res; 2016 Nov; 152():57-70. PubMed ID: 27639516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Descemet's Membrane Endothelial Keratoplasty for Fuchs Endothelial Dystrophy versus Bullous Keratopathy: Histopathology and Clinical Results.
    Brockmann T; Brockmann C; Maier AB; Schroeter J; Bertelmann E; Torun N
    Curr Eye Res; 2018 Oct; 43(10):1221-1227. PubMed ID: 29939775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of cell-based therapy combined with descemetorhexis for treating Fuchs endothelial corneal dystrophy in rabbit model.
    Okumura N; Matsumoto D; Fukui Y; Teramoto M; Imai H; Kurosawa T; Shimada T; Kruse F; Schlötzer-Schrehardt U; Kinoshita S; Koizumi N
    PLoS One; 2018; 13(1):e0191306. PubMed ID: 29338061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Factors for Clinical Outcomes after Primary Descemet's Membrane Endothelial Keratoplasty for Fuchs' Endothelial Dystrophy.
    Brockmann T; Pilger D; Brockmann C; Maier AB; Bertelmann E; Torun N
    Curr Eye Res; 2019 Feb; 44(2):147-153. PubMed ID: 30339062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta ig-h3 is synthesized by corneal epithelium and perhaps endotheliumin Fuchs' dystrophic corneas.
    Hirano K; Klintworth GK; Zhan Q; Bennett K; Cintron C
    Curr Eye Res; 1996 Sep; 15(9):965-72. PubMed ID: 8921218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.